Hong Kong-listed CSPC Pharmaceutical Group Ltd. said it received approval from the China Securities Regulatory Commission to list CSPC XNW Pharmaceutical Joint Stock Company Ltd and its subsidiaries on Chinext, a Nasdaq-style board of the Shenzhen Stock Exchange.

CSPC XNW is an indirect non-wholly owned subsidiary of CSPC that manufactures and sells caffeine, vitamin C health supplements, and beverage products.

The listing is subject to obtaining formal written approval and other processes.